InhA-IN-3

CAS No. 900701-83-9

InhA-IN-3( —— )

Catalog No. M35482 CAS No. 900701-83-9

InhA-IN-3 (TU13) is a potent inhibitor of Mycobacterium tuberculosis InhA (enoyl ACP reductase) with potential anticancer and antiproliferative activities for the study of Mycobacterium tuberculosis infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 532 In Stock
5MG 922 In Stock
10MG 1140 In Stock
25MG 1463 In Stock
50MG 1822 In Stock
100MG 2250 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    InhA-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    InhA-IN-3 (TU13) is a potent inhibitor of Mycobacterium tuberculosis InhA (enoyl ACP reductase) with potential anticancer and antiproliferative activities for the study of Mycobacterium tuberculosis infections.
  • Description
    InhA-IN-3 (Compound TU12) is a Mycobacterium tuberculosis InhA (an enoyl ACP-reductase) inhibitor with an IC50 of 17.7 μM.
  • In Vitro
    InhA-IN-3 (Compound TU12) shows antitubercular activity with a MIC of 0.78±0.59 μg/mL against Mycobacterium tuberculosis.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    900701-83-9
  • Formula Weight
    321.78
  • Molecular Formula
    C14H12ClN3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [O-][N+](=O)C1=CC=C(NC(=S)NCC2=C(Cl)C=CC=C2)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Do?an ?D, et al. Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors. Eur J Med Chem. 2020 Aug 1;199:112402.?
molnova catalog
related products
  • Azithromycin

    A macrolide antibiotic used for the treatment of a number of bacterial infections.

  • ClpB-IN-1

    ClpB-IN-1 is a potential antimicrobial agent.ClpB-IN-1 is a potent ClpB inhibitor.

  • Pleuromutilin

    Pleuromutilin is an inhibitor of bacterial protein synthesis by binding to the 50S ribosomal subunit of bacteria.